{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:35:54Z","timestamp":1774384554352,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1245\/s10434-024-15369-8","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T15:02:34Z","timestamp":1716476554000},"page":"5102-5110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Validation of the Safety and Efficacy of Apixaban as Postoperative Thromboembolism Prophylaxis for Patients with Gynecologic Malignancies"],"prefix":"10.1245","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-6245","authenticated-orcid":false,"given":"Jessica","family":"Floyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector","family":"Porragas-Paseiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa R.","family":"Moroney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Mastroyannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saketh R.","family":"Guntupalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"15369_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/AOG.0b013e31823d389e","volume":"119","author":"DL Clarke-Pearson","year":"2012","unstructured":"Clarke-Pearson DL, Abaid LN. Prevention of venous thromboembolic events after gynecologic surgery. Obstet Gynecol. 2012;119:155\u201367.","journal-title":"Obstet Gynecol."},{"issue":"140","key":"15369_CR2","first-page":"e1","volume":"229","author":"JS Taylor","year":"2023","unstructured":"Taylor JS, et al. Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023;229(140):e1\u20137.","journal-title":"Am J Obstet Gynecol."},{"key":"15369_CR3","doi-asserted-by":"publisher","first-page":"e072715","DOI":"10.1136\/bmj-2022-072715","volume":"381","author":"SR Guntupalli","year":"2023","unstructured":"Guntupalli SR, et al. Prevention of venous thromboembolism in patients with cancer. BMJ. 2023;381:e072715.","journal-title":"BMJ."},{"key":"15369_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MBC.0000000000000193","volume":"26","author":"G Kourlaba","year":"2015","unstructured":"Kourlaba G, et al. The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review. Blood Coagul Fibrinolysis. 2015;26:13\u201331.","journal-title":"Blood Coagul Fibrinolysis."},{"key":"15369_CR5","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.23.00294","volume":"41","author":"NS Key","year":"2023","unstructured":"Key NS, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Guideline Update. J Clin Oncol. 2023;41:3063\u201371.","journal-title":"J Clin Oncol."},{"key":"15369_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/0147-7447-20050201-16","volume":"28","author":"CW Colwell Jr","year":"2005","unstructured":"Colwell CW Jr, et al. Patient compliance with outpatient prophylaxis: an observational study. Orthopedics. 2005;28:143\u20137.","journal-title":"Orthopedics."},{"key":"15369_CR7","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1006885","volume":"363","author":"MR Lassen","year":"2010","unstructured":"Lassen MR, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363:2487\u201398.","journal-title":"N Engl J Med."},{"key":"15369_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(09)62125-5","volume":"375","author":"MR Lassen","year":"2010","unstructured":"Lassen MR, et al. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375:807\u201315.","journal-title":"Lancet."},{"key":"15369_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1056\/NEJMoa0810773","volume":"361","author":"MR Lassen","year":"2009","unstructured":"Lassen MR, et al. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. N Engl J Med. 2009;361:594\u2013604.","journal-title":"N Engl J Med."},{"key":"15369_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13643-021-01814-2","volume":"10","author":"LI Lavikainen","year":"2021","unstructured":"Lavikainen LI, et al. Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology. Syst Rev. 2021;10:264.","journal-title":"Syst Rev."},{"key":"15369_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","volume":"159","author":"A Glickman","year":"2020","unstructured":"Glickman A, et al. Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery. Gynecol Oncol. 2020;159:476\u201382.","journal-title":"Gynecol Oncol."},{"key":"15369_CR12","doi-asserted-by":"publisher","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, et al. Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Netw Open. 2020;3:e207410.","journal-title":"JAMA Netw Open."},{"key":"15369_CR13","first-page":"1181","volume":"19","author":"MB Streiff","year":"2021","unstructured":"Streiff MB, et al. Cancer-associated venous thromboembolic disease, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2021;19:1181\u2013201.","journal-title":"J Natl Compr Cancer Netw."},{"key":"15369_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/MCP.0b013e32833c3d3e","volume":"16","author":"JA Caprini","year":"2010","unstructured":"Caprini JA. Risk assessment as a guide to thrombosis prophylaxis. Curr Opin Pulm Med. 2010;16:448\u201352.","journal-title":"Curr Opin Pulm Med."},{"key":"15369_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.thromres.2019.07.021","volume":"181","author":"C Joos","year":"2019","unstructured":"Joos C, et al. Accuracy of ICD-10 codes for identifying hospitalizations for acute anticoagulation therapy-related bleeding events. Thromb Res. 2019;181:71\u20136.","journal-title":"Thromb Res."},{"issue":"Suppl 1","key":"15369_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pds.2341","volume":"21","author":"L Tamariz","year":"2012","unstructured":"Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):154\u201362.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"15369_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11239-019-01885-y","volume":"48","author":"K Lawrence","year":"2019","unstructured":"Lawrence K, et al. Assessing the accuracy of ICD-10 codes for identifying acute thromboembolic events among patients receiving anticoagulation therapy. J Thromb Thrombolysis. 2019;48:181\u20136.","journal-title":"J Thromb Thrombolysis."},{"key":"15369_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11239-006-5573-x","volume":"21","author":"PS Wells","year":"2006","unstructured":"Wells PS. Advances in the diagnosis of venous thromboembolism. J Thromb Thrombolysis. 2006;21:31\u201340.","journal-title":"J Thromb Thrombolysis."},{"key":"15369_CR19","unstructured":"Team RC. A Language and Environment for Statistical Computing, 2023. R Foundation for Statistical Computing, Vienna, Austria."},{"key":"15369_CR20","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/IGC.0000000000000912","volume":"27","author":"A Graul","year":"2017","unstructured":"Graul A, et al. Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer. 2017;27:581\u20137.","journal-title":"Int J Gynecol Cancer."},{"key":"15369_CR21","doi-asserted-by":"publisher","first-page":"10407","DOI":"10.1007\/s00520-022-07433-4","volume":"30","author":"S Wu","year":"2022","unstructured":"Wu S, et al. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis. Support Care Cancer. 2022;30:10407\u201320.","journal-title":"Support Care Cancer."},{"key":"15369_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ygyno.2023.02.012","volume":"172","author":"E Spenard","year":"2023","unstructured":"Spenard E, et al. Apixaban for extended postoperative thromboprophylaxis in gynecologic oncology patients undergoing laparotomy. Gynecol Oncol. 2023;172:9\u201314.","journal-title":"Gynecol Oncol."},{"key":"15369_CR23","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1055\/s-0041-1735194","volume":"122","author":"G Agnelli","year":"2022","unstructured":"Agnelli G, et al. Apixaban and dalteparin for the treatment of venous thromboembolism in patients with different sites of cancer. Thromb Haemost. 2022;122:796\u2013807.","journal-title":"Thromb Haemost."},{"key":"15369_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ejogrb.2018.09.028","volume":"230","author":"P Marques de Marino","year":"2018","unstructured":"Marques de Marino P, et al. Thromboprophylaxis in gynecologic cancer surgery: is extended prophylaxis with low-molecular-weight heparin justified? Eur J Obstet Gynecol Reprod Biol. 2018;230:90\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"15369_CR25","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archinte.160.6.809","volume":"160","author":"JA Heit","year":"2000","unstructured":"Heit JA, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160:809\u201315.","journal-title":"Arch Intern Med."},{"key":"15369_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/JCO.19.01461","volume":"38","author":"NS Key","year":"2020","unstructured":"Key NS, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020;38:496\u2013520.","journal-title":"J Clin Oncol."},{"key":"15369_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","volume":"173","author":"A Li","year":"2019","unstructured":"Li A, et al. Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer-associated thrombosis (CAT): a systematic review and meta-analysis. Thromb Res. 2019;173:158\u201363.","journal-title":"Thromb Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15369-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15369-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:07:34Z","timestamp":1720645654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15369-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["15369"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15369-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"22 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}